MD Anderson Cancer Center and Sanofi announced a five-year strategic collaboration to accelerate the development of investigational treatments, including targeted and immune therapies, for patients with cancer.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
